Skip to main content

Cosmetic Approach During Pregnancy

  • Living reference work entry
  • Latest version View entry history
  • First Online:
Daily Routine in Cosmetic Dermatology

Abstract

Pregnancy is a very special moment for every woman, and some physiologic changes occur in her body, including the skin. Skin treatment can be necessary to control some disease that can begin or get worse during pregnancy, and dermatologists must know what can or cannot be prescribed during this period. Clinical and side effects of many different medicaments are well studied and when correctly indicated they can be used. On the other hand, few data about the benefits and the harmfulness of cosmetics and cosmeceuticals is available. This chapter will approach what is known about cosmetics and cosmeceuticals, the indication and the contraindication of these products during pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Akhavan A, Bershad S. Topical acne drugs: review of clinical properties, systemic exposure, and safety. Am J Clin Dermatol. 2003;4:473–92.

    Article  PubMed  Google Scholar 

  • Andersen F. Amended final report on the safety assessment of ethyl methacrylate. Int J Toxicol. 2002;21(Suppl):63–79.

    CAS  Google Scholar 

  • Andersen A. Amended final report of the safety assessment of dibutyl adipate as used in cosmetics. Int J Toxicol. 2006;25 Suppl 1:129–34.

    PubMed  Google Scholar 

  • Bozzo P, Chua-Gocheco A, Einarson A. Safety of skin care products during pregnancy. Can Fam Phys Le Méd Famille Can. 2011;57:665–7.

    Google Scholar 

  • Brennan M, Young G, Devane D. Topical preparations for preventing stretch marks in pregnancy. Cochrane Database Syst Rev. 2012; 11:CD000066. doi:10.1002/14651858.CD000066.pub2.

    Google Scholar 

  • Burnett CL, Bergfeld WF MD, FACP, Belsito DV MD, Hill RA PhD, Klaassen CD PhD, Liebler DC PhD, Marks Jr JG MD, Shank RC PhD, Slaga TJ PhD, Snyder PW DVM, PhD, Andersen FA PhD, Burnett CL, Bergfeld WF, Belsito DV, et al. Final report of the safety assessment of kojic acid as used in cosmetics. Int J Toxicol. 2010;29:244S–73.

    Article  CAS  PubMed  Google Scholar 

  • Camera G, Pregliasco P. Ear malformation in baby born to mother using tretinoin cream. Lancet. 1992;339:687.

    Article  CAS  PubMed  Google Scholar 

  • Choi CM, Berson DS. Cosmeceuticals. Semin Cutan Med Surg. 2006;25(3):163–8.

    Article  CAS  PubMed  Google Scholar 

  • Cilliers J. Use of kojic acid to treat superficial cutaneous hyperpigmentation. Disponível em: http://www.magiclear.co.za/MagiClearKojicAcid.html

  • Couto AC, Ferreira JD, Rosa ACS, Pombo-de-Oliveira MS, Koifman S, Brazilian Collaborative Study Group of Infant Acute Leukemia. Pregnancy, maternal exposure to hair dyes and hair straightening cosmetics, and early age leukemia. Chem Biol Interact. 2013;205:46–52.

    Article  CAS  PubMed  Google Scholar 

  • del Rosso JQ. Moisturizers: function, formulation and clinical applications. capitulo 14 pags 97 a 102) in Cosmeceuticals Draelos. 2009:97–102.

    Google Scholar 

  • Dickenson CA MA, Woodruff TJ, Stotland NE, Dobraca D, Das R. Elevated mercury levels in pregnant woman linked to skin cream from Mexico. Am J Obstet Gynecol Case Rep. 2013;209:e4–5.

    Article  CAS  Google Scholar 

  • Duarte I, Buense R, Lazzarini R. Cosméticos na Gravidez. In: Tedesco JJA, editor. A Grávida: suas indagações e as dúvidas do Obstetra. São Paulo: Editora Atheneu; 1999. p. 141–65.

    Google Scholar 

  • Elder RL. Final report on the safety assessment of ethyl acetate and butyl acetate. J Am Coll Toxicol. 1989;8:681–705.

    Article  Google Scholar 

  • Ema M, Miyawaki E, Kawashima K. Further evaluation of developmental toxicity of di n-butyl phthalate following administration during late pregnancy in rats. Toxicol Lett. 1998;98:87–93.

    Article  CAS  PubMed  Google Scholar 

  • Grunewald S, Jank A. New systemic agents in dermatology with respect to fertility, pregnancy, and lactation. J Ger Soc Dermatol. 2015;1304:277–90.

    Google Scholar 

  • Jick SS, Terris BZ, Jick H. First trimester topical tretinoin and congenital disorders. Lancet. 1993;341:1181–2.

    Article  CAS  PubMed  Google Scholar 

  • Johnson Jr W. Safety assessment of MIBK (Methyl Isobutyl Ketone). Int J Toxicol. 2004;23(Suppl):29–57.

    CAS  PubMed  Google Scholar 

  • Kligman AM. O que são cosmecêuticos. In: Draelos ZD, Dover JS, editors. Cosmecêuticos. Rio de Janeiro: Elsevier; 2005a. p. 1–2.

    Google Scholar 

  • Kligman A. The future of cosmeceuticals: an interview with Albert Kligman, MD, PhD. Dermatol Surg. 2005b;31(7 part 2):890–1.

    CAS  PubMed  Google Scholar 

  • Kroumpouzos G, Draelos Z. Skin care products, cosmetics and cosmeceuticals. In: Kroumpouzos G, editor. Text atlas of obstetric dermatology. Philadelphia: Lippincott Williams & Wilkins Publishers; 2013. p. 251–7.

    Google Scholar 

  • Leachman AS, Reed BR. The use of dermatologic drugs in pregnancy and lactation. Dermatol Clin. 2006;24:167–97.

    Article  CAS  PubMed  Google Scholar 

  • Levy S. Estimated exposure to phthalates in cosmetics and risk assessment. J Toxicol Environ Health. 2004;67:23–4.

    Article  Google Scholar 

  • Lipson AH, Collins F, Webster WS. Multiple congenital defects associated with maternal use of topical tretinoin. Lancet. 1993;341:1352–3.

    Article  CAS  PubMed  Google Scholar 

  • Loureiro KD, Kao KK, Jones KL, Alvarado S, Chavez C, Dick L, Felix R, Johnson D, Chambers CD. Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy birth outcomes and topical tretinoin. Am J Med Genet. 2005;136A:117–21.

    Article  Google Scholar 

  • Mahé A, Perret JL, Ly F, Fall F, Rault JP, Dumont A. The cosmetic use of skin-lightening products during pregnancy in Dakar, Senegal: a common and potentially hazardous practice. Trans R Soc Trop Med Hyg. 2007;101:183–7.

    Article  PubMed  Google Scholar 

  • Nakagawa M, Kawai K, Kawai K. Contact allergy to kojic acid in skin care products. Contact Dermatitis. 1995;32(1):9–13.

    Article  CAS  PubMed  Google Scholar 

  • Navarre-Belhassen C, Blanchet P, Hillaire-Buys D, et al. Multiple congenital malformations associated with topical tretinoin. Ann Pharmacother. 1998;32:505–6.

    Article  CAS  PubMed  Google Scholar 

  • Odio MR, et al. Evaluation of subchronic (13 week), reproductive, and in vitro genetic toxicity potential of 2-ethylhexyl-2-cyano-3,3-diphenyl acrylate (octocrylene). Fundam Appl Toxicol. 1994;22(3):355–68.

    Article  CAS  PubMed  Google Scholar 

  • Panchaud AP, Csajka C, Merlob P, Sshaefer C, Berlin M, De Santis M, Vial T, Ieri A, Malm H, Eleftheriou G, Stahl B, Rousso P, Winterfield U, Rothuizen LE, Buclin T. Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study. J Clin Pharmacol. 2012;52:1844–51.

    Article  CAS  PubMed  Google Scholar 

  • Purim KSM, Avelar MFS. Fotoproteção, melasma e qualidade de vida em gestantes. Photoprotection, melasma and quality of life in pregnant women. Rev Bras Ginecol Obstet. 2012;34(5):228–34.

    Article  PubMed  Google Scholar 

  • Shapiro L, Pastuszak A, Curto G, Koren G. Safety of first-trimester exposure to topical tretinoin: prospective cohort study. Lancet. 1997;350:1143–4.

    Article  CAS  PubMed  Google Scholar 

  • Simion FA, Abrutyn ES, Draelos ZD. Ability of moisturizers to reduce dry skin and irritations and to prevent their return. J Cosmet Sci. 2005;56(6):427–44.

    CAS  PubMed  Google Scholar 

  • Tyl RW, Price CJ, Marr MC, et al. Developmental toxicity evaluation of sodium thioglycolate administered topically to Sprague-Dawley (CD) rats and New Zealand white rabbits. Birth Defects Res B Dev Reprod Toxicol. 2003;68(2):144–61.

    Article  CAS  PubMed  Google Scholar 

  • Wehr RF, Krochmal L. Considerations in selecting a moisturizer. Cutis. 1987;39:512–5.

    CAS  PubMed  Google Scholar 

  • Wster RC, Melendres J, Hui X, Cox R, Serranzana S, Zhai H, Quan D, Maibach HI. Human in vivo and in vitro, hydroquinone topical biovailability, metabolism, and disposition. J Toxicol Environ Health A. 1998;54(4):301–17.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luna Azulay-Abulafia .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this entry

Cite this entry

Azulay-Abulafia, L., de Oliveira Vieira, E. (2017). Cosmetic Approach During Pregnancy. In: Issa, M., Tamura, B. (eds) Daily Routine in Cosmetic Dermatology. Clinical Approaches and Procedures in Cosmetic Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-20250-1_23-2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-20250-1_23-2

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-20250-1

  • Online ISBN: 978-3-319-20250-1

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Cosmetic Approach During Pregnancy
    Published:
    20 March 2017

    DOI: https://doi.org/10.1007/978-3-319-20250-1_23-2

  2. Original

    Cosmiatric Approach During Pregnancy
    Published:
    19 December 2016

    DOI: https://doi.org/10.1007/978-3-319-20250-1_23-1